Our CEO Dexter Tjoa sat down with Pharma Manufacturing Magazine to discuss the future of drug development and manufacturing as we navigate through 2023 and beyond, with groundbreaking trends like AI technology, innovative dosage forms, and sustainable practices reshaping the industry and transforming packaging requirements.

Dexter believes that embracing these changes brings promising advancements and opportunities, but also poses challenges that pharma manufacturers must conquer to thrive in this dynamic landscape.

Click here to read the full article.